Olichon Aurélien, Surrey Thomas
Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
J Biol Chem. 2007 Dec 14;282(50):36314-20. doi: 10.1074/jbc.M704908200. Epub 2007 Oct 5.
Genetically encoded fluorescent antibodies are desirable for many applications in biotechnology and proteomics. However, the efficient production of single chain antibodies fused to fluorescent proteins like green fluorescent protein is still a major challenge. This is due to the opposite redox requirements of recombinant antibodies and fluorescent proteins for proper folding. To overcome this obstacle, we designed a novel strategy to directly select functional fluorescent antibodies (fluobodies) engineered for efficient cytosolic expression in Escherichia coli, starting from a llama heavy chain antibody (VHH) library. We used this strategy to produce several VHH fluobodies directed against microtubules. After biochemical characterization in vitro, we used a selected fluobody as a convenient biomarker of the microtubule cytoskeleton in eukaryotic cells and engineered its properties. This work provides a reliable approach for the production of fluobodies in wild-type E. coli and furthermore suggests that fusions of recombinant VHH with other cytosolic proteins are now possible, creating new opportunities for biotechnology and biomedical research.
基因编码的荧光抗体在生物技术和蛋白质组学的许多应用中都很有需求。然而,与绿色荧光蛋白等荧光蛋白融合的单链抗体的高效生产仍然是一个重大挑战。这是由于重组抗体和荧光蛋白正确折叠所需的氧化还原条件相反。为了克服这一障碍,我们设计了一种新策略,从羊驼重链抗体(VHH)文库开始,直接筛选经过工程改造以在大肠杆菌中高效胞质表达的功能性荧光抗体(荧光体)。我们使用该策略生产了几种针对微管的VHH荧光体。在体外进行生化表征后,我们将一种选定的荧光体用作真核细胞中微管细胞骨架的便捷生物标志物,并对其性质进行了改造。这项工作为在野生型大肠杆菌中生产荧光体提供了一种可靠的方法,此外还表明重组VHH与其他胞质蛋白的融合现在是可行的,为生物技术和生物医学研究创造了新机会。